These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12928064)

  • 1. Achieving healthy people 2010 immunization goals: proceedings of a national conference. Chapel Hill, North Carolina: October 12-13, 2001. Economics of immunization.
    Sisk J
    Clin Ther; 2003; 25 Suppl A():A9-A17. PubMed ID: 12928064
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving healthy people 2010 immunization goals: proceedings of a national conference. Chapel Hill, North Carolina: October 12-13, 2001. Background.
    Lyles A
    Clin Ther; 2003; 25 Suppl A():A2-8. PubMed ID: 12928063
    [No Abstract]   [Full Text] [Related]  

  • 3. Achieving healthy people 2010 immunization goals: proceedings of a national conference. Chapel Hill, North Carolina: October 12-13, 2001.
    Massoudi M
    Clin Ther; 2003; 25 Suppl A():A18-32. PubMed ID: 12928065
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines of the Pharmaceutical Benefits Board for health economics evaluations. Cost-efficiency analysis from a national perspective].
    Lundin D; Carlsson P; Levin LA; Persson U
    Lakartidningen; 2006 Nov 22-28; 103(47):3716-8. PubMed ID: 17212321
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost effectiveness of health insurance.
    Muennig P; Franks P; Gold M
    Am J Prev Med; 2005 Jan; 28(1):59-64. PubMed ID: 15626556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of preventive vaccinations in Bavaria 1985--5 years following the assumption of costs by legal health insurance].
    Stehr K
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):767-70. PubMed ID: 4069119
    [No Abstract]   [Full Text] [Related]  

  • 8. Experts recommend that US insurers should cover immunisations.
    Charatan F
    BMJ; 2003 Aug; 327(7411):360. PubMed ID: 12919977
    [No Abstract]   [Full Text] [Related]  

  • 9. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket costs of childhood immunizations: a comparison by type of insurance plan.
    Molinari NA; Kolasa M; Messonnier ML; Schieber RA
    Pediatrics; 2007 Nov; 120(5):e1148-56. PubMed ID: 17974710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The income-associated burden of disease in the United States.
    Muennig P; Franks P; Jia H; Lubetkin E; Gold MR
    Soc Sci Med; 2005 Nov; 61(9):2018-26. PubMed ID: 15913866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded programme on immunization.
    Int J Epidemiol; 1990 Mar; 19(1):219-20. PubMed ID: 2351517
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health insurance coverage and cost barriers to needed medical care among U.S. adult cancer survivors age<65 years.
    Sabatino SA; Coates RJ; Uhler RJ; Alley LG; Pollack LA
    Cancer; 2006 Jun; 106(11):2466-75. PubMed ID: 16639732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 18. Workshop on acute respiratory diseases among children of the world. Proceedings of a conference May 18-19, 1983. Chapel Hill, North Carolina.
    Pediatr Res; 1983 Dec; 17(12):1023-76. PubMed ID: 6657323
    [No Abstract]   [Full Text] [Related]  

  • 19. [National economic consequences of vaccines].
    Bergman A; Persson U
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1680-4. PubMed ID: 18590011
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related quality of life among North Carolina adults with diabetes mellitus.
    Wubben DP; Porterfield D
    N C Med J; 2005; 66(3):179-85. PubMed ID: 16130940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.